Moderna, Inc. (MRNA) vs United Therapeutics Corporation (UTHR)

A side-by-side comparison of Moderna, Inc. and United Therapeutics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.

Compare
Moderna, Inc. logo
MRNA
Moderna, Inc.
$22.14B
$55.81HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
United Therapeutics Corporation logo
UTHR
United Therapeutics Corporation
$22.23B
$523.63HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT

Total return — MRNA vs UTHR

growth of $100 · dividends reinvested · last 8y
MRNA +199.1%UTHR +368.2%UTHR compounded faster
05001k2k2k3kStart $1002020202220242026$299$468
MRNA UTHR

MRNA vs UTHR: by the numbers

  • •UTHR is the larger company ($22.23B vs $22.14B market cap).
  • •UTHR is profitable (40.61% net margin) while MRNA runs a net loss (-143.55%).
  • •MRNA grew revenue faster over the past five years (19.33% vs 16.05% CAGR).

Metrics side by side

Valuation

MetricMRNAUTHR
P/E ratioN/A19.52
Forward P/EN/A18.94
P/S ratio9.887.86
P/B ratio2.974.22
PEG ratioN/A1.16
EV / EBITDAN/A15.63
FCF yieldN/A4.08%

Profitability

MetricMRNAUTHR
Gross margin55.35%86.58%
Operating margin-153.35%45.34%
Net margin-143.55%40.61%
ROE-43.12%21.82%
ROIC-29.70%16.13%

Growth (annualized)

MetricMRNAUTHR
Revenue CAGR (5Y)19.33%16.05%
EPS CAGR (5Y)N/A20.93%
FCF CAGR (5Y)N/A12.12%
Total return CAGR (5Y)-31.25%23.16%

Frequently asked

Which has grown faster, MRNA or UTHR?
Over the past five years, MRNA grew revenue faster — MRNA at a 19.33% CAGR versus UTHR at 16.05%.
Is MRNA or UTHR more profitable?
UTHR runs the higher net margin — MRNA at -143.55% versus UTHR at 40.61%.
How have MRNA and UTHR total returns compared?
Over the past 5 years, MRNA delivered -31.25% and UTHR delivered 16.65% annualized total return. Past performance doesn't predict future results.

Go deeper

Full MRNA analysisFull UTHR analysisInteractive comparison tool

Dig into the metrics

Moderna P/E ratioUnited Therapeutics P/E ratioModerna dividend yieldUnited Therapeutics dividend yieldModerna ROEUnited Therapeutics ROEModerna operating marginUnited Therapeutics operating marginModerna revenue growthUnited Therapeutics revenue growthModerna free cash flowUnited Therapeutics free cash flow

Moderna & United Therapeutics appear in these rankings

Fastest Revenue Growth StocksHighest Operating Margin StocksHighest FCF Yield StocksHighest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.